Cargando…

Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe

BACKGROUND: Despite funding constraints for treatment programmes in Africa, the costs and economic consequences of routine laboratory monitoring for efficacy and toxicity of antiretroviral therapy (ART) have rarely been evaluated. METHODS: Cost-effectiveness analysis was conducted in the DART trial...

Descripción completa

Detalles Bibliográficos
Autores principales:	Medina Lara, Antonieta, Kigozi, Jesse, Amurwon, Jovita, Muchabaiwa, Lazarus, Nyanzi Wakaholi, Barbara, Mujica Mota, Ruben E., Walker, A. Sarah, Kasirye, Ronnie, Ssali, Francis, Reid, Andrew, Grosskurth, Heiner, Babiker, Abdel G., Kityo, Cissy, Katabira, Elly, Munderi, Paula, Mugyenyi, Peter, Hakim, James, Darbyshire, Janet, Gibb, Diana M., Gilks, Charles F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3335836/ https://www.ncbi.nlm.nih.gov/pubmed/22545079 http://dx.doi.org/10.1371/journal.pone.0033672

Ejemplares similares

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort
por: Walker, AS, et al.
Publicado: (2010)

Mortality in the Year Following Antiretroviral Therapy Initiation in HIV-Infected Adults and Children in Uganda and Zimbabwe
por: Walker, A. Sarah, et al.
Publicado: (2012)

A Single CD4 Test with 250 Cells/Mm(3) Threshold Predicts Viral Suppression in HIV-Infected Adults Failing First-Line Therapy by Clinical Criteria
por: Gilks, Charles F., et al.
Publicado: (2013)

Early mortality following ART initiation in HIV-infected adults and children in Uganda and Zimbabwe
por: Walker, AS, et al.
Publicado: (2010)

High Level of Viral Suppression and Low Switch Rate to Second-Line Antiretroviral Therapy among HIV-Infected Adult Patients Followed over Five Years: Retrospective Analysis of the DART Trial
por: Kityo, Cissy, et al.
Publicado: (2014)

Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study
por: Gomo, Zvenyika AR, et al.
Publicado: (2014)

The Impact of Different CD4 Cell-Count Monitoring and Switching Strategies on Mortality in HIV-Infected African Adults on Antiretroviral Therapy: An Application of Dynamic Marginal Structural Models
por: Ford, Deborah, et al.
Publicado: (2015)

Impact of the adolescent and youth sexual and reproductive health strategy on service utilisation and health outcomes in Zimbabwe
por: Muchabaiwa, Lazarus, et al.
Publicado: (2019)

Implementation of antiretroviral therapy for life in pregnant/breastfeeding HIV+ women (Option B+) alongside rollout and changing guidelines for ART initiation in rural Zimbabwe: the Lablite Project experience
por: Ford, Deborah, et al.
Publicado: (2017)

The Lablite project: A cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe
por: Chan, Adrienne K, et al.
Publicado: (2014)

Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30–49 vs ≥50 mL/min
por: Ross, Lisa L., et al.
Publicado: (2019)

The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint Clinical Research Centre, Uganda
por: Kigozi, Brian K, et al.
Publicado: (2009)

Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV-infected patients on antiretroviral therapy in sub-Saharan Africa*
por: Kasirye, R, et al.
Publicado: (2015)

Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design
por: Anywaine, Zacchaeus, et al.
Publicado: (2015)

Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled study
por: Kasirye, Ronnie, et al.
Publicado: (2016)

Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study
por: Kasirye, Ronnie P., et al.
Publicado: (2016)

Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults
por: Kasirye, Ronnie P., et al.
Publicado: (2017)

Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial
por: Anywaine, Zacchaeus, et al.
Publicado: (2018)

Exit interviews administered to patients participating in the COSTOP placebo controlled randomised trial in Uganda
por: Nunn, Andrew, et al.
Publicado: (2016)

Validation of World Health Organisation HIV/AIDS Clinical Staging in Predicting Initiation of Antiretroviral Therapy and Clinical Predictors of Low CD4 Cell Count in Uganda
por: Baveewo, Steven, et al.
Publicado: (2011)

Clinical Differences between Younger and Older Adults with HIV/AIDS Starting Antiretroviral Therapy in Uganda and Zimbabwe: A Secondary Analysis of the DART Trial
por: Parikh, Sujal M., et al.
Publicado: (2013)

Rapid accumulation of HIV-1 thymidine analogue mutations and phenotypic impact following prolonged viral failure on zidovudine-based first-line ART in sub-Saharan Africa
por: Goodall, Ruth L., et al.
Publicado: (2017)

Towards 90-90-90 Target: Factors Influencing Availability, Access, and Utilization of HIV Services—A Qualitative Study in 19 Ugandan Districts
por: Bajunirwe, Francis, et al.
Publicado: (2018)

The relevance of timing of illness and death events in the household life cycle for coping outcomes in rural Uganda in the era of HIV
por: Amurwon, Jovita, et al.
Publicado: (2015)

Identification of gaps for implementation science in the HIV prevention, care and treatment cascade; a qualitative study in 19 districts in Uganda
por: Bajunirwe, Francis, et al.
Publicado: (2016)

Hepatitis B serological markers and plasma DNA concentrations
por: Price, Huw, et al.
Publicado: (2017)

Persistence of traditional and emergence of new structural drivers and factors for the HIV epidemic in rural Uganda; A qualitative study
por: Bajunirwe, Francis, et al.
Publicado: (2019)

Shifting human resources for health in the context of ART provision: qualitative and quantitative findings from the Lablite baseline study
por: Nkhata, Misheck J., et al.
Publicado: (2016)

“Helping my neighbour is like giving a loan…” –the role of social relations in chronic illness in rural Uganda
por: Amurwon, Jovita, et al.
Publicado: (2017)

High Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy
por: Gupta, Ravindra K., et al.
Publicado: (2014)

A Randomized, Controlled, Trial of Short Cycle Intermittent Compared to Continuous Antiretroviral Therapy for the Treatment of HIV Infection in Uganda
por: Reynolds, Steven J., et al.
Publicado: (2010)

Virological findings from the SARA trial: boosted PI monotherapy as maintenance second-line ART in Africa
por: Pillay, D, et al.
Publicado: (2010)

CD8(+) T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4(+) T Cells <200 Cell/μL: The DART Trial STI Substudy
por: Serwanga, Jennifer, et al.
Publicado: (2011)

Acceptability of a Mobile Phone Support Tool (Call for Life Uganda) for Promoting Adherence to Antiretroviral Therapy Among Young Adults in a Randomized Controlled Trial: Exploratory Qualitative Study
por: Twimukye, Adelline, et al.
Publicado: (2021)

Population level usage of health services, and HIV testing and care, prior to decentralization of antiretroviral therapy in Agago District in rural Northern Uganda
por: Abongomera, G., et al.
Publicado: (2015)

Vitamin D deficiency and its characteristics among patients with acute stroke at a national referral hospital in Kampala Uganda
por: Kiggundu, Daniel S., et al.
Publicado: (2015)

Synsepalum chimanimani (Sapotaceae), a new species from the Chimanimani Mountains of Mozambique and Zimbabwe, with notes on the botanical importance of this area
por: Rokni, Saba, et al.
Publicado: (2019)

Pregnancy and Infant Outcomes among HIV-Infected Women Taking Long-Term ART with and without Tenofovir in the DART Trial
por: Gibb, Diana M., et al.
Publicado: (2012)

Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda
por: Goodall, R. L., et al.
Publicado: (2014)

Determinants of Clinician Knowledge on Aging and HIV/AIDS: A Survey of Practitioners and Policy Makers in Kampala District, Uganda
por: Obuku, Ekwaro A., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vs7hv7tune331s2i7o4pgqtqgq